FMC (FMC) Wolfe Research Materials of the Future Conference summary
Event summary combining transcript, slides, and related documents.
Wolfe Research Materials of the Future Conference summary
3 Feb, 2026Leadership and management changes
CEO transition: Mark Douglas stepped down, Pierre Brondeau returned as CEO, ensuring continuity and operational focus.
Mark Douglas remains as executive advisor through September 1 to support a smooth transition.
Leadership transition expected to be seamless due to Brondeau's deep familiarity with the company and management team.
Market and industry environment
Crop protection chemical consumption by growers remains steady and growing globally, despite recent industry corrections.
Inventory normalization is underway, with the U.S. most advanced, Brazil healthy, Europe improving, and Asia mixed, especially India.
Transition from correction to recovery is evident, but volatility is expected in the next few quarters.
Regional performance and demand trends
U.S. and Brazil show improved inventory levels and renewed customer engagement compared to 2023.
Brazil's agricultural sector remains resilient, with healthy planting intentions and good acreage expected for the next season.
Asia faces inventory challenges, particularly in India, due to less favorable monsoon seasons.
Latest events from FMC
- Q1 2026 revenue and EBITDA declined, but guidance was reaffirmed amid restructuring and headwinds.FMC
Q1 202629 Apr 2026 - Financial review, board changes, and strategic alternatives—including a possible sale—highlighted.FMC
AGM 202629 Apr 2026 - Dirk A. Kempthorne is no longer a board nominee; all other proxy matters remain unchanged.FMC
Proxy filing27 Apr 2026 - Executing asset sales, cost cuts, and licensing to drive growth and restore competitiveness.FMC
Bank of America 2026 Global Agriculture and Materials Conference9 Apr 2026 - Strategic options, pipeline innovation, and financial restructuring drive future growth.FMC
JPMorgan Industrials Conference 202618 Mar 2026 - Key governance, compensation, and shareholder rights reforms headline the 2026 annual meeting.FMC
Proxy Filing13 Mar 2026 - Key votes include director elections, say-on-pay, and expanded shareholder rights proposals.FMC
Proxy Filing13 Mar 2026 - Proxy seeks approval for director elections, governance reforms, and a new performance-based incentive plan.FMC
Proxy Filing3 Mar 2026 - 2025 losses deepen on price pressure and impairment; 2026 outlook cautious amid strategic review.FMC
Q4 20255 Feb 2026